Make Sure You Stick With Design Therapeutics Inc (DSGN). It’s Bull Time Again

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Design Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Design Therapeutics Inc is $264.94M. A total of 1.28 million shares were traded on the day, compared to an average of 290.02K shares.

In the most recent transaction, Schmid John P. bought 17,809 shares of DSGN for 3.74 per share on Mar 25 ’24. After the transaction, the Director now owns 26,965 company shares. In a previous transaction on Mar 25 ’24, Berger Heather A. bought 1,300 shares at 3.74 per share. DSGN shares that Director owns now total 1,300.

Among the insiders who bought shares, Schmid John P. acquired of 9,156 shares on Mar 22 ’24 at a per-share price of $3.62. This resulted in the Director holding 9,156 shares of DSGN after the transaction. In another insider transaction, LAPPE RODNEY W bought 21,000 shares at $2.35 per share on Sep 29 ’23. Company shares held by the Director now total 133,024.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DSGN has a high of $8.47 and a low of $1.94.

As of this writing, DSGN has an earnings estimate of -$0.26 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.35 in the last quarter

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DSGN’s latest balance sheet shows that the firm has $384.06M in Cash & Short Term Investments as of fiscal 2021. There were $3.63M in debt and $5.28M in liabilities at the time. Its Book Value Per Share was $4.92, while its Total Shareholder’s Equity was $382.13M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DSGN is Buy with a score of 3.00.

Most Popular

Related Posts